1. Early Onset Severe Hypertensive Disease in Pregnancy and Screening for Antiphospholipid Syndrome
- Author
-
Nasim C. Sobhani, Rachel Shulman, Erin E. Tran, and Juan M. Gonzalez
- Subjects
antiphospholipid syndrome ,preterm preeclampsia ,antiphospholipid screening ,severe hypertensive disease of pregnancy ,antiphospholipid antibodies ,Gynecology and obstetrics ,RG1-991 - Abstract
Objective Although preterm delivery (PTD) before 34 weeks for severe hypertensive disease is a diagnostic criterion for antiphospholipid syndrome (APS), there is no consensus regarding testing for antiphospholipid antibodies (aPL) in this setting. We aim to describe the frequency of and the characteristics associated with inpatient aPL testing in this population. Study Design In this retrospective study of PTD before 34 weeks for severe hypertensive disease, charts were reviewed for aPL testing, gestational age at delivery, fetal complications, and severity of maternal disease. Wilcoxon rank-sum test, Fisher's exact, and chi-squared tests were used for analyses of continuous and categorical variables, and multivariate logistic regression for adjusted odds ratios. Results Among 133 cases, 14.3% had APS screening via aPL testing. Screened patients delivered earlier than unscreened patients (28.9 vs. 31.7 weeks, p
- Published
- 2020
- Full Text
- View/download PDF